Cargando…

Liver and kidney dysfunction, hypoglycemia, and thrombocytopenia in Plasmodium vivax malaria patients at a Colombian Northwest region

Plasmodium vivax has high morbidity, it is the Plasmodium species with the greatest worldwide distribution, and its ability to trigger severe symptoms is currently recognized. The present study aims to compare the clinical and epidemiological characteristics of patients with P. vivax malaria, with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tovar-Acero, Catalina, Velasco, María Camila, Avilés-Vergara, Paula Andrea, Ricardo-Caldera, Dina Marcela, Alvis, Erasmo Manuel, Ramirez - Montoya, Javier, Yasnot Acosta, Maria Fernanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881263/
https://www.ncbi.nlm.nih.gov/pubmed/33615000
http://dx.doi.org/10.1016/j.parepi.2021.e00203
_version_ 1783650842518224896
author Tovar-Acero, Catalina
Velasco, María Camila
Avilés-Vergara, Paula Andrea
Ricardo-Caldera, Dina Marcela
Alvis, Erasmo Manuel
Ramirez - Montoya, Javier
Yasnot Acosta, Maria Fernanda
author_facet Tovar-Acero, Catalina
Velasco, María Camila
Avilés-Vergara, Paula Andrea
Ricardo-Caldera, Dina Marcela
Alvis, Erasmo Manuel
Ramirez - Montoya, Javier
Yasnot Acosta, Maria Fernanda
author_sort Tovar-Acero, Catalina
collection PubMed
description Plasmodium vivax has high morbidity, it is the Plasmodium species with the greatest worldwide distribution, and its ability to trigger severe symptoms is currently recognized. The present study aims to compare the clinical and epidemiological characteristics of patients with P. vivax malaria, with and without complication criteria, in an endemic area for malaria transmission in northwest Colombia. A descriptive cross-sectional study was carried out between 2017 and 2019, patients with P.vivax severe malaria (n = 50), non-severe malaria (n = 56) and healthy controls (n = 50) were included. Sociodemographic, clinical, hematological, and biochemical characteristics were analyzed. Clinical follow-up was carried out in a group of patients with severe malaria. The statistical analysis was carried out in GraphPad Prism; the Chi-square test analyzed categorical variables, comparisons of variables for the three groups were carried out by the Kruskal-Wallis test and comparison between two groups by the Mann-Whitney test. A multiple correspondence analysis described the relationship between variables, which was carried out through the R software. One hundred fifty-six individuals were linked to the study, 76 women and 80 men, between 3 and 71 years old. For 50% of the patients, it was their first malaria episode; 42% of the patients classified with severe malaria required hospitalization, compared to 7.1% of the patients with non-severe malaria. Parasitaemia was similar in both clinical groups; however, 10% of severe patients presented high parasitemia, between 20,000-135,000. The most frequent clinical characteristics in patients with severe malaria were severe thrombocytopenia in 54%, hypoglycemia in 48%, and liver and kidney failure in 30%. Biochemical and hematological parameters returned to normal in 90% of the patients with severe malaria on the third day after starting treatment. Thrombocytopenia, hypoglycemia, and liver and kidney dysfunctions were the most frequent P. vivax malaria complications in this study. Hemoglobin concentration and parasite count were not related to the clinical condition of patients. Thrombocytopenia was the most frequent finding in patients with malaria, and its severity presented an inverse relationship with the number of previous malaria episodes.
format Online
Article
Text
id pubmed-7881263
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78812632021-02-18 Liver and kidney dysfunction, hypoglycemia, and thrombocytopenia in Plasmodium vivax malaria patients at a Colombian Northwest region Tovar-Acero, Catalina Velasco, María Camila Avilés-Vergara, Paula Andrea Ricardo-Caldera, Dina Marcela Alvis, Erasmo Manuel Ramirez - Montoya, Javier Yasnot Acosta, Maria Fernanda Parasite Epidemiol Control Original Research article Plasmodium vivax has high morbidity, it is the Plasmodium species with the greatest worldwide distribution, and its ability to trigger severe symptoms is currently recognized. The present study aims to compare the clinical and epidemiological characteristics of patients with P. vivax malaria, with and without complication criteria, in an endemic area for malaria transmission in northwest Colombia. A descriptive cross-sectional study was carried out between 2017 and 2019, patients with P.vivax severe malaria (n = 50), non-severe malaria (n = 56) and healthy controls (n = 50) were included. Sociodemographic, clinical, hematological, and biochemical characteristics were analyzed. Clinical follow-up was carried out in a group of patients with severe malaria. The statistical analysis was carried out in GraphPad Prism; the Chi-square test analyzed categorical variables, comparisons of variables for the three groups were carried out by the Kruskal-Wallis test and comparison between two groups by the Mann-Whitney test. A multiple correspondence analysis described the relationship between variables, which was carried out through the R software. One hundred fifty-six individuals were linked to the study, 76 women and 80 men, between 3 and 71 years old. For 50% of the patients, it was their first malaria episode; 42% of the patients classified with severe malaria required hospitalization, compared to 7.1% of the patients with non-severe malaria. Parasitaemia was similar in both clinical groups; however, 10% of severe patients presented high parasitemia, between 20,000-135,000. The most frequent clinical characteristics in patients with severe malaria were severe thrombocytopenia in 54%, hypoglycemia in 48%, and liver and kidney failure in 30%. Biochemical and hematological parameters returned to normal in 90% of the patients with severe malaria on the third day after starting treatment. Thrombocytopenia, hypoglycemia, and liver and kidney dysfunctions were the most frequent P. vivax malaria complications in this study. Hemoglobin concentration and parasite count were not related to the clinical condition of patients. Thrombocytopenia was the most frequent finding in patients with malaria, and its severity presented an inverse relationship with the number of previous malaria episodes. Elsevier 2021-01-25 /pmc/articles/PMC7881263/ /pubmed/33615000 http://dx.doi.org/10.1016/j.parepi.2021.e00203 Text en © 2021 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research article
Tovar-Acero, Catalina
Velasco, María Camila
Avilés-Vergara, Paula Andrea
Ricardo-Caldera, Dina Marcela
Alvis, Erasmo Manuel
Ramirez - Montoya, Javier
Yasnot Acosta, Maria Fernanda
Liver and kidney dysfunction, hypoglycemia, and thrombocytopenia in Plasmodium vivax malaria patients at a Colombian Northwest region
title Liver and kidney dysfunction, hypoglycemia, and thrombocytopenia in Plasmodium vivax malaria patients at a Colombian Northwest region
title_full Liver and kidney dysfunction, hypoglycemia, and thrombocytopenia in Plasmodium vivax malaria patients at a Colombian Northwest region
title_fullStr Liver and kidney dysfunction, hypoglycemia, and thrombocytopenia in Plasmodium vivax malaria patients at a Colombian Northwest region
title_full_unstemmed Liver and kidney dysfunction, hypoglycemia, and thrombocytopenia in Plasmodium vivax malaria patients at a Colombian Northwest region
title_short Liver and kidney dysfunction, hypoglycemia, and thrombocytopenia in Plasmodium vivax malaria patients at a Colombian Northwest region
title_sort liver and kidney dysfunction, hypoglycemia, and thrombocytopenia in plasmodium vivax malaria patients at a colombian northwest region
topic Original Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881263/
https://www.ncbi.nlm.nih.gov/pubmed/33615000
http://dx.doi.org/10.1016/j.parepi.2021.e00203
work_keys_str_mv AT tovaracerocatalina liverandkidneydysfunctionhypoglycemiaandthrombocytopeniainplasmodiumvivaxmalariapatientsatacolombiannorthwestregion
AT velascomariacamila liverandkidneydysfunctionhypoglycemiaandthrombocytopeniainplasmodiumvivaxmalariapatientsatacolombiannorthwestregion
AT avilesvergarapaulaandrea liverandkidneydysfunctionhypoglycemiaandthrombocytopeniainplasmodiumvivaxmalariapatientsatacolombiannorthwestregion
AT ricardocalderadinamarcela liverandkidneydysfunctionhypoglycemiaandthrombocytopeniainplasmodiumvivaxmalariapatientsatacolombiannorthwestregion
AT alviserasmomanuel liverandkidneydysfunctionhypoglycemiaandthrombocytopeniainplasmodiumvivaxmalariapatientsatacolombiannorthwestregion
AT ramirezmontoyajavier liverandkidneydysfunctionhypoglycemiaandthrombocytopeniainplasmodiumvivaxmalariapatientsatacolombiannorthwestregion
AT yasnotacostamariafernanda liverandkidneydysfunctionhypoglycemiaandthrombocytopeniainplasmodiumvivaxmalariapatientsatacolombiannorthwestregion